JERUSALEM & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced availability of the FDA-approved generic version of EpiPen Jr®1 (epinephrine ...

Woman injecting herself in the thigh. The 60-year-old male patient presented to the ED complaining of "the worst pain in his life" in his right thigh. A rare case of clostridial gas gangrene following ...

Richmond, Virginia, May 15, 2025 (GLOBE NEWSWIRE) -- New findings from a retrospective analysis of U.S. commercial claims data indicate that patients prescribed AUVI-Q ® (epinephrine injection, USP) ...

Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjectors may have little effect on surviving anaphylaxis events. Research is needed in ...

Certain lots of Amneal’s Epinephrine Injection, Autoinjector 0.3mg may not contain the yellow "stop collar" that is necessary for proper dosing of the anaphylaxis treatment, according to the FDA.

My son Thomas has carried around a needle since he entered kindergarten at the age of 5. That was a big responsibility for a small child to carry an injector loaded with lifesaving epinephrine, but ...

Woman’s hand holding a unused epinephrine Auto injector. The device is commonly used to treat the life threatening immune response known as anaphylaxis. A survey explored triggers for use of ...

Please provide your email address to receive an email when new articles are posted on . Although current guidelines recommend calls to emergency medical services and ED visits in response to ...

The pharmacodynamics profile for 13.2-mg IN epinephrine in the opposite or same nostrils was comparable to that of the 0.3-mg autoinjector and 0.5-mg manual syringe. Intranasal (IN) epinephrine is ...

Friendly epinephrine? Meet Neffy, ARS Pharmaceuticals’ nasal spray epinephrine to treat severe allergic reactions to food, medicines and insect bites. Neffy, now awaiting FDA approval, aims to flip ...

ALK presents new findings that directly compare user preference between needle-free nasal and injectable adrenaline treatments for anaphylaxis, demonstrating that 88% of participants prefer ...